PureTech Health

Yahoo Finance • 28 days ago

PureTech reports FY results, will delist ADS from Nasdaq

* PureTech press release [https://seekingalpha.com/pr/20491791-puretech-announces-annual-results-for-year-ended-december-31-2025] (PRTC [https://seekingalpha.com/symbol/PRTC]): FY  Consolidated cash, cash equivalents and short-term inves... Full story

Yahoo Finance • 29 days ago

Psychiatry Drugmaker Seaport Seeks $212.4 Million in US IPO

(Bloomberg) -- Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise $212.4 million in a US initial public offering. Most Read from Bloomberg Sergey Brin Confr... Full story

Yahoo Finance • 30 days ago

PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors

BOSTON, April 27, 2026--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes... Full story

Yahoo Finance • 9 months ago

PureTech Health plc reports 1H results

* PureTech Health plc press release [https://seekingalpha.com/pr/20214107-puretech-health-plc-half-year-report] (OTC:PTCHF [https://seekingalpha.com/symbol/PTCHF]): 1H ~$320M PureTech level cash, cash equivalents and short-term investment... Full story

Yahoo Finance • 9 months ago

Former Teva North America CEO to lead PureTech's new respiratory entity

BOSTON - PureTech Health plc (NASDAQ:PRTC, LSE:PRTC), a $420 million market cap biotech company with a "GOOD" overall financial health score according to InvestingPro, announced Tuesday the launch of Celea Therapeutics, a new entity focuse... Full story

Yahoo Finance • 10 months ago

PureTech Health CEO Bharatt Chowrira Steps Down; Names Robert Lyne Interim CEO

(RTTNews) - PureTech Health plc (PRTC, PRTC.L) announced Wednesday that Bharatt Chowrira has stepped down today from his role as Chief Executive Officer and as a member of the Board of Directors. The company noted that it has appointed Ro... Full story

Yahoo Finance • 11 months ago

PureTech Health issues shares to executives following RSU vesting

LONDON - PureTech Health plc (Nasdaq:PRTC, LSE: PRTC) has issued ordinary shares to four executives following the vesting of restricted share units (RSUs), according to a company statement released Friday. The biotherapeutics company issu... Full story

Yahoo Finance • 11 months ago

PureTech Health issues shares to non-executive directors as RSUs vest

LONDON - PureTech Health plc (Nasdaq:PRTC, LSE: PRTC) has issued ordinary shares to six non-executive directors following the vesting of previously granted restricted share units (RSUs), according to a company statement released Friday. T... Full story

Yahoo Finance • 11 months ago

PureTech Health announces RSU vesting and share transactions by PDMR

LONDON - PureTech Health plc (Nasdaq:PRTC, LSE: PRTC) reported Friday that Robert Lyne, Chief Portfolio Officer, received vested ordinary shares on July 1, 2025, as part of restricted share units (RSUs) granted on March 4, 2024, under the... Full story

Yahoo Finance • 2 years ago

PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion

Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease T... Full story

Yahoo Finance • 3 years ago

PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia

Results demonstrate KarXT was not associated with clinically meaningful increases in blood pressure in adults with schizophrenia KarXT demonstrated a mean change from baseline to week 8 in 24-hour ambulatory systolic blood pressure of -0.... Full story

Yahoo Finance • 3 years ago

Results of PureTech's Annual General Meeting

BOSTON, June 13, 2023--(BUSINESS WIRE)--The Annual General Meeting of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech Health" or the "Company") was held at 11 a.m. EDT/4 p.m. BST on Tuesday, June 13, 2023. All of the resolutions... Full story

Yahoo Finance • 3 years ago

PureTech Health: Notice of Results

BOSTON, April 13, 2023--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its annual report and financial results on Friday, April 28, 2023, at 2:00 AM EDT/ 7:00 AM BST. The repor... Full story

Yahoo Finance • 3 years ago

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

Project to leverage vocal biomarkers for cognitive assessment of patients ages 55 and above in home environment BOSTON, February 27, 2023--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a cli... Full story

Yahoo Finance • 3 years ago

PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers

Orally administered LYT-300 achieved blood levels of allopregnanolone at or above those associated with therapeutic effect.1 Allopregnanolone is a natural neurosteroid with proven efficacy that is currently only available as a 60-hour intr... Full story

Yahoo Finance • 3 years ago

10 Best Immunology Stocks to Invest In

In this article, we discuss the 10 best immunology stocks to invest in. If you want to read about some more immunology stocks, go directly to 5 Best Immunology Stocks to Invest In. Immunology is the study of the immune system of higher or... Full story

Yahoo Finance • 4 years ago

PureTech to Present at the Morgan Stanley Global Healthcare Conference

BOSTON, September 08, 2022--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today... Full story

Yahoo Finance • 4 years ago

PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan

Pivotal study follows successful Phase 2 trial, which demonstrated improvements in attention function as compared to both treatment as usual and single task video game groups Pivotal Data Readout expected in 2H2023 BOSTON, August 01, 202... Full story

Yahoo Finance • 4 years ago

FDA panel to review Moderna vaccine in children aged 6 to 17, and Rolling Stones front man Mick Jagger tests positive for COVID

An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17.... Full story

Yahoo Finance • 4 years ago

PureTech to Present at the UBS Global Healthcare Conference

BOSTON, May 17, 2022--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated med... Full story